ALHC - Alignment Healthcare, Inc. Stock Price, Fair Value and News

5.12USD-0.06 (-1.16%)Delayed as of 25 Apr 2024, 09:48 am ET

Market Summary

USD5.12-0.06

Delayedas of 25 Apr 2024, 09:48 am

-1.16%

ALHC Alerts

1 major insider buys and 2 major insider sales recently.

ALHC Stock Price

View Fullscreen

ALHC RSI Chart

ALHC Valuation

Market Cap

978.9M

Price/Earnings (Trailing)

-6.61

Price/Sales (Trailing)

0.54

EV/EBITDA

-8.9

Price/Free Cashflow

-16.54

ALHC Price/Sales (Trailing)

ALHC Profitability

EBT Margin

-8.13%

Return on Equity

-94.31%

Return on Assets

-25.01%

Free Cashflow Yield

-6.05%

ALHC Fundamentals

ALHC Revenue

Revenue (TTM)

1.8B

Rev. Growth (Yr)

28.63%

Rev. Growth (Qtr)

1.9%

ALHC Earnings

Earnings (TTM)

-148.0M

Earnings Growth (Yr)

17.04%

Earnings Growth (Qtr)

-34.7%

Breaking Down ALHC Revenue

52 Week Range

5.077.62

(Low)(High)

Last 7 days

4.7%

Last 30 days

11.9%

Last 90 days

-22.9%

Trailing 12 Months

-4.6%

How does ALHC drawdown profile look like?

ALHC Financial Health

Current Ratio

1.84

Debt/Equity

1.03

Debt/Cashflow

-0.37

ALHC Investor Care

Shares Dilution (1Y)

0.91%

Diluted EPS (TTM)

-0.79

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	1.5B	1.6B	1.7B	1.8B
2022	1.2B	1.3B	1.4B	1.4B
2021	1.0B	1.1B	1.1B	1.2B
2020	807.5M	858.1M	908.7M	959.2M
2019	0	0	0	757.0M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Alignment Healthcare, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 28, 2024	scavo robert l.	sold	-8,813	4.84	-1,821	chief information officer
Mar 28, 2024	maroney dawn christine	sold	-49,130	4.84	-10,151	president, markets
Mar 28, 2024	freeman robert thomas	sold	-20,807	4.84	-4,299	chief financial officer
Mar 28, 2024	kardes hakan	sold	-21,116	4.84	-4,363	chief experience officer
Mar 20, 2024	maroney dawn christine	sold	-64,007	4.83	-13,252	president, markets
Mar 19, 2024	kim hyong	sold	-28,163	5.0508	-5,576	chief medical officer
Mar 19, 2024	maroney dawn christine	sold	-80,110	5.0508	-15,861	president, markets
Mar 19, 2024	joyce christopher j	sold	-126,573	5.0508	-25,060	chief legal and admin. officer
Mar 19, 2024	scavo robert l.	sold	-15,546	5.0508	-3,078	chief information officer
Mar 19, 2024	freeman robert thomas	sold	-144,059	5.0508	-28,522	chief financial officer

Which funds bought or sold ALHC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	AMALGAMATED BANK	reduced	-77.61	-96,000	14,000	-%
Apr 22, 2024	Raymond James Financial Services Advisors, Inc.	new	-	580,900	580,900	-%
Apr 22, 2024	RAYMOND JAMES & ASSOCIATES	new	-	708,422	708,422	-%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	76,710	395,492	-%
Apr 19, 2024	DENALI ADVISORS LLC	added	82.53	74.00	1,503	-%
Apr 18, 2024	BARLOW WEALTH PARTNERS, INC.	sold off	-100	-100,461	-	-%
Apr 18, 2024	Allspring Global Investments Holdings, LLC	added	9.2	-115,724	196,267	-%
Apr 18, 2024	Capital Advisors, Ltd. LLC	sold off	-100	-1,000	-	-%
Apr 05, 2024	CWM, LLC	reduced	-34.39	-1,000	1,000	-%
Apr 05, 2024	GAMMA Investing LLC	reduced	-45.09	-6,199	4,246	-%

Are Funds Buying or Selling ALHC?

Are funds buying ALHC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ALHC

No. of Funds

ALHC Alerts

1 major insider buys and 2 major insider sales recently.

Unveiling Alignment Healthcare, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	t. rowe price investment management, inc.	6.4%	12,075,504	SC 13G
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Feb 13, 2023	general atlantic, l.p.	32.6%	60,993,323	SC 13G/A
Feb 10, 2023	warburg pincus private equity xii, l.p.	6.16%	11,544,243	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Feb 14, 2022	warburg pincus private equity xii, l.p.	7.8%	14,665,604	SC 13G
Feb 11, 2022	general atlantic, l.p.	37.4%	70,069,317	SC 13G
Feb 09, 2022	fmr llc	-	0	SC 13G

Recent SEC filings of Alignment Healthcare, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 12, 2024	PRE 14A	PRE 14A
Mar 29, 2024	4	Insider Trading
Mar 29, 2024	4	Insider Trading
Mar 29, 2024	4	Insider Trading
Mar 29, 2024	4	Insider Trading
Mar 28, 2024	144	Notice of Insider Sale Intent
Mar 28, 2024	144	Notice of Insider Sale Intent
Mar 28, 2024	144	Notice of Insider Sale Intent
Mar 28, 2024	144	Notice of Insider Sale Intent
Mar 21, 2024	4	Insider Trading

Peers (Alternatives to Alignment Healthcare, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	449.3B	371.6B	0.31%	-0.92%	20.08	1.21	14.64%	11.24%
CI	103.0B	195.3B	-0.92%	38.85%	19.17	0.53	8.17%	-20.79%
CVS	85.3B	357.8B	-14.21%	-7.01%	10.21	0.24	10.95%	93.52%
HCA	84.4B	65.0B	-2.46%	13.22%	16.11	1.3	7.86%	-7.11%
CNC	40.8B	154.0B	-1.12%	9.99%	15.09	0.26	6.54%	124.79%
DVA	11.6B	12.1B	-1.51%	52.05%	16.83	0.96	4.57%	23.40%
UHS	11.5B	14.3B	-6.67%	17.96%	16.03	0.81	6.59%	6.24%
MID-CAP
CHE	9.3B	2.3B	-4.23%	9.23%	34.28	4.13	6.06%	9.17%
ACHC	6.6B	2.9B	-6.62%	-3.50%	-303.23	2.24	12.20%	-107.93%
AMN	2.2B	3.8B	-8.18%	-34.26%	10.28	0.57	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.68%	1.59%	33.78	1.48	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-7.02%	-15.70%	24.79	1.46	11.31%	35.83%
BKD	1.3B	3.0B	4.49%	59.95%	-6.76	0.42	6.74%	20.73%
BEAT	54.0M	-	-6.82%	-	-3.69	-	-	-12.94%
AMS	19.1M	21.3M	14.29%	7.64%	35.87	0.9	8.00%	-62.25%

Alignment Healthcare, Inc. News

Latest updates

Alignment Healthcare, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Revenue	1.9%	465,387,000	456,709,000	462,379,000	439,155,000	361,811,000	360,348,000	366,474,000	345,526,000	298,274,000	293,466,000	308,951,000	267,082,000	242,409,000	247,867,000	244,313,000	224,633,000	-
Operating Expenses	4.3%	507,300,000	486,465,000	486,038,000	471,644,000	413,917,000	393,758,000	373,122,000	382,001,000	341,740,000	334,916,000	349,443,000	319,746,000	270,204,000	232,807,000	231,726,000	229,748,000	-
S&GA Expenses	0.8%	83,737,000	83,089,000	70,199,000	70,408,000	83,228,000	76,452,000	61,673,000	74,293,000	78,081,000	76,846,000	71,150,000	64,914,000	51,119,000	38,794,000	33,698,000	32,787,000	-
EBITDA Margin	14.9%	-0.06	-0.07	-0.08	-0.07	-0.08	-0.08	-0.09	-0.12	-0.14	-0.13	-0.08	-0.04	0.01	-	-	-	-
Interest Expenses	0.3%	5,484,000	5,466,000	5,262,000	5,019,000	4,793,000	4,605,000	4,490,000	4,401,000	4,452,000	4,414,000	4,329,000	4,248,000	4,308,000	4,271,000	4,192,000	4,160,000	-
Income Taxes	-Infinity%	-24,000	-	1,000	1,000	172,000	167,000	-	-	-	-	-	-	-	-	-	-	-
Earnings Before Taxes	-34.7%	-47,255,000	-35,077,000	-28,493,000	-37,370,000	-56,823,000	-40,080,000	-11,580,000	-40,817,000	-47,834,000	-45,816,000	-44,762,000	-56,874,000	-32,065,000	10,846,000	8,365,000	-10,072,000	-
EBT Margin	11.4%	-0.08	-0.09	-0.10	-0.10	-0.10	-0.10	-0.11	-0.14	-0.17	-0.16	-0.12	-0.07	-0.02	-	-	-	-
Net Income	-34.7%	-47,209,000	-35,047,000	-28,477,000	-37,284,000	-56,903,000	-40,247,000	-11,580,000	-40,817,000	-47,834,000	-45,816,000	-44,762,000	-56,874,000	-32,065,000	10,846,000	8,365,000	-10,072,000	-
Net Income Margin	11.5%	-0.08	-0.09	-0.10	-0.10	-0.10	-0.10	-0.11	-0.14	-0.17	-0.16	-0.12	-0.07	-0.02	-	-	-	-
Free Cashflow	-3228.6%	-187,466,000	5,992,000	37,177,000	85,110,000	-149,263,000	105,120,000	10,354,000	-11,638,000	-30,134,000	12,914,000	-23,449,000	-38,107,000	-10,146,000	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet														(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2019Q4
Assets	-23.2%	592	771	784	762	634	778	667	647	631	657	670	679	339	193
Current Assets	-27.5%	484	667	684	671	545	692	586	566	553	577	593	605	265	127
Cash Equivalents	-48.2%	203	392	395	384	410	567	453	449	467	500	495	528	208	86.00
Net PPE	10.0%	52.00	47.00	43.00	40.00	37.00	36.00	33.00	32.00	30.00	32.00	30.00	28.00	27.00	27.00
Goodwill	-	35.00	-	-	-	35.00	-	-	-	-	-	-	-	-	-
Liabilities	-25.4%	434	581	572	538	395	505	373	353	325	332	330	325	308	272
Current Liabilities	-35.9%	263	410	402	374	230	340	214	195	167	175	174	170	153	130
Long Term Debt	0.1%	162	162	161	161	161	161	154	152	151	149	147	146	144	138
LT Debt, Non Current	0.1%	162	162	161	161	161	161	154	152	151	149	147	146	144	138
Shareholder's Equity	-16.7%	157	189	211	224	238	272	294	293	306	325	340	354	31.00	79.00
Retained Earnings	-5.7%	-880	-833	-798	-769	-732	-675	-635	-623	-582	-527	-481	-436	-379	-78.71
Additional Paid-In Capital	1.5%	1,037	1,021	1,008	992	970	947	929	917	889	852	821	791	410	-
Shares Outstanding	0.0%	189	189	189	188	187	187	187	187	187	187	187	187	-	-
Minority Interest	2.1%	1.00	1.00	1.00	1.00	1.00	-	-	0.00	0.00	0.00	0.00	-	-	-
Float	-	-	-	675	-	-	-	950	-	-	-	1,321	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																	(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Cashflow From Operations	-3228.6%	-187,466	5,992	37,177	85,110	-149,263	105,120	10,354	-11,638	-30,134	12,914	-23,449	-38,107	-10,146	26,039	13,487	-21,819	-
Share Based Compensation	15.4%	15,652	13,569	15,636	21,978	22,885	18,687	12,099	28,047	28,814	30,511	30,887	31,787	1,144	304	350	326	-
Cashflow From Investing	89.4%	-1,018	-9,607	-26,210	-110,428	-8,107	-8,128	-5,855	-6,127	-2,951	-6,997	-6,421	-4,446	-4,725	-4,258	-3,640	-3,735	-
Cashflow From Financing	-	45.00	-	30.00	30.00	-527	17,220	-100	-	-	-	-3,529	363,659	-144	-338	-878	131,484	-
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	1,474	144	338	507	516	-

ALHC Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues:
Earned premiums	$ 1,800,933	$ 1,431,550	$ 1,167,085
Other	22,697	2,609	688
Total revenues	$ 1,823,630	$ 1,434,159	$ 1,167,773
Revenue, Product and Service [Extensible List]	us-gaap:FinancialServiceMember	us-gaap:FinancialServiceMember	us-gaap:FinancialServiceMember
Expenses:
Medical expenses	$ 1,622,600	$ 1,249,879	$ 1,039,041
Selling, general, and administrative expenses	307,433	295,646	290,991
Depreciation and amortization	21,414	17,273	15,813
Total expenses	1,951,447	1,562,798	1,345,845
Loss from operations	(127,817)	(128,639)	(178,072)
Other expenses:
Interest expense	21,231	18,289	17,443
Other expenses (income)	(853)	176	(229)
Loss on extinguishment of debt	0	2,196	0
Total other expenses	20,378	20,661	17,214
Loss before income taxes	(148,195)	(149,300)	(195,286)
Provision for income taxes	(22)	339	0
Net loss	(148,173)	(149,639)	(195,286)
Less: Net loss attributable to noncontrolling interest	156	92	0
Net loss attributable to Alignment Healthcare, Inc.	$ (148,017)	$ (149,547)	$ (195,286)
Total weighted-average common shares outstanding - basic	186,214,784	181,212,757	171,956,849
Total weighted-average common shares outstanding - diluted	186,214,784	181,212,757	171,956,849
Net loss per share attributable to Alignment Healthcare, Inc. - basic	$ (0.79)	$ (0.83)	$ (1.14)
Net loss per share attributable to Alignment Healthcare, Inc. - diluted	$ (0.79)	$ (0.83)	$ (1.14)

ALHC Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 202,904	$ 409,549
Accounts receivable (less allowance for credit losses of $0 at December 31, 2023 and 2022)	119,749	92,890
Prepaid expenses and other current assets	44,970	42,107
Investments - current	115,914	0
Total current assets	483,537	544,546
Property and equipment, net	51,901	37,169
Right of use asset, net	9,959	5,825
Goodwill	34,826	34,810
Intangible Assets, net	5,252	5,478
Other assets	6,405	6,035
Total assets	591,880	633,863
Current Liabilities:
Medical expenses payable	205,399	170,135
Accounts payable and accrued expenses	23,511	32,288
Accrued compensation	34,112	27,538
Total current liabilities	263,022	229,961
Long-term debt, net of debt issuance costs	161,813	160,902
Long-term portion of lease liabilities	8,974	3,698
Total liabilities	433,809	394,561
Commitments and Contingencies (Note 14)
Stockholders' Equity:
Preferred stock, $.001 par value; 100,000,000 shares authorized as of December 31, 2023 and 2022, respectively; no shares issued and outstanding as of December 31, 2023 and 2022	0	0
Common stock, $.001 par value; 1,000,000,000 shares authorized as of December 31, 2023 and December 31, 2022; 188,951,643 and 187,280,015 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	189	187
Additional paid-in capital	1,037,015	970,180
Accumulated deficit	(880,258)	(732,241)
Total Alignment Healthcare, Inc. stockholders' equity	156,946	238,126
Noncontrolling interest	1,125	1,176
Total stockholders' equity	158,071	239,302
Total liabilities and stockholders' equity	$ 591,880	$ 633,863

About Alignment Healthcare, Inc.

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, Nevada, Arizona, Florida, and Texas. The company was founded in 2013 and is based in Orange, California.

CEO	Mr. John E. Kao
WEBSITE	alignmenthealthcare.com
INDUSTRY	Healthcare Plans
EMPLOYEES	1037

Alignment Healthcare, Inc. Frequently Asked Questions

What is the ticker symbol for Alignment Healthcare, Inc.? What does ALHC stand for in stocks?

ALHC is the stock ticker symbol of Alignment Healthcare, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Alignment Healthcare, Inc. (ALHC)?

As of Wed Apr 24 2024, market cap of Alignment Healthcare, Inc. is 978.9 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ALHC stock?

You can check ALHC's fair value in chart for subscribers.

What is the fair value of ALHC stock?

You can check ALHC's fair value in chart for subscribers. The fair value of Alignment Healthcare, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Alignment Healthcare, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ALHC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Alignment Healthcare, Inc. a good stock to buy?

The fair value guage provides a quick view whether ALHC is over valued or under valued. Whether Alignment Healthcare, Inc. is cheap or expensive depends on the assumptions which impact Alignment Healthcare, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ALHC.

What is Alignment Healthcare, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 24 2024, ALHC's PE ratio (Price to Earnings) is -6.61 and Price to Sales (PS) ratio is 0.54. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ALHC PE ratio will change depending on the future growth rate expectations of investors.